North Carolina Novo Nordisk’s GLP-1 Pill Makes Key Progress Oct 21, 2025 Novo Nordisk's pill, oral semaglutide, has scored approval for slashing cardiovascular risks, further confirming its health benefits beyond diabetes treatment.
Health & Wellness Trump’s Health Care Bill Risks Coverage for Millions, Threatens Rural… Jul 1, 2025 Trump's "big, beautiful bill" plans sweeping changes to U.S. healthcare, potentially leaving millions uninsured and…